Engineering and Structural Characterization of a Linear Polyubiquitin-Specific Antibody

https://doi.org/10.1016/j.jmb.2011.12.053Get rights and content
Under a Creative Commons license
open access

Abstract

Polyubiquitination is an essential posttranslational modification that plays critical roles in cellular signaling. PolyUb (polyubiquitin) chains are formed by linking the carboxyl-terminus of one Ub (ubiquitin) subunit to either a lysine residue or the amino-terminus of an adjacent Ub. Linkage through the amino-terminus results in linear polyubiquitination that has recently been demonstrated to be a key step in nuclear factor κB activation; however, tools to study linear chains have been lacking. We therefore engineered a linear-linkage-specific antibody that is functional in Western blot, immunoprecipitation, and immunofluorescence applications. A crystal structure of the linear-linkage-specific antibody Fab fragment in complex with linear diubiquitin provides molecular insight into the nature of linear chain specificity. We use the antibody to demonstrate that linear polyUb is up-regulated upon tumor necrosis factor α stimulation of cells, consistent with a critical role in nuclear factor κB signaling. This antibody provides an essential tool for further investigation of the function of linear chains.

Graphical Abstract

Highlights

► A linear polyUb antibody with exquisite specificity was engineered. ► The antibody recognizes a conformational epitope unique to linear-linked chains. ► Linear chains are up-regulated upon tumor necrosis factor α stimulation of cells.

Abbreviations used

NFκB
nuclear factor κB
LUBAC
linear Ub chain assembly complex
IF
immunofluorescence
IP
immunoprecipitation
CDR
complementarity-determining region
AQUA
absolute quantification
TNF
tumor necrosis factor
PDB
Protein Data Bank
PBS
phosphate-buffered saline
EDTA
ethylenediaminetetraacetic acid

Keywords

ubiquitin
linkage
phage display
immunoglobulin
X-ray crystallography

Cited by (0)

1

Present address: M. L. Matsumoto, Sutro Biopharma, Inc., 310 Utah Avenue, Suite 150, South San Francisco, CA 94080, USA.